Wikidata

(Q82206056)

English

Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells

scientific article published on 02 October 2008

In more languages

Statements

title
Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18835037
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835037%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q82206056&oldid=2141108170"